Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery.

518 indexed citations

Abstract

loading...

About

This paper, published in 2002, received 518 indexed citations. Written by John W. Park, Keelung Hong, Dmitri B. Kirpotin, Gail Colbern, Refaat Shalaby, José Baselga, Yvonne Shao, Ulrik B. Nielsen, James D. Marks and Dan H. Moore covering the research area of Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. It is primarily cited by scholars working on Molecular Biology (326 citations), Biomaterials (301 citations) and Biomedical Engineering (175 citations). Published in PubMed.

In The Last Decade

doi.org/w9137893 →

Countries where authors are citing Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery.

Specialization
Citations

This map shows the geographic impact of Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery.. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery. with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery. more than expected).

Fields of papers citing Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery.

Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery.. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery..

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

This paper is also available at doi.org/w9137893.

Explore hit-papers with similar magnitude of impact

Rankless by CCL
2026